Advertisement
ProteinSimple
ProteinSimple

GeneLink Settles

Another personal genomics company faces government pressure—this time from the Federal Trade Commission.

By | January 14, 2014

FLICKR, BRADLEY STEMKEJust a month after personal genomics company 23andMe announced that it would stop offering health interpretations of genetic data amidst pressure from the U.S. Food and Drug Administration, another personal genomics company is under government fire. The Federal Trade Commission (FTC) announced in a press release dated January 7 that GeneLink Biosciences, Inc., and its former subsidiary, Foru International Corp., agreed “to settle Federal Trade Commission charges of deceptive advertising for claims that their personalized nutritional supplements treat diabetes, heart disease, arthritis, insomnia, and other ailments.”

Both companies marketed supplements and skincare products allegedly customized to customers’ genomes that cost at least $100 a month. The FTC also took issue with lax security regarding customers’ personal information—including Social Security numbers and genetic data. “It doesn’t matter whether the claims deal with the benefits of direct-to-consumer genetic testing or the privacy of personal information,” Jessica Rich, the director of the FTC’s Bureau of Consumer Protection, said in the statement. “It’s against the law to deceive people about your product and to make promises you don’t keep.”

Under the terms of the settlement, GeneLink and Foru are prohibited from marketing their products as treatments for any disease, unless the claim has been validated in well-controlled studies; from making any assertions about their products improving health by modulating gene function; and from providing the means for any affiliated companies or individuals to make health claims about their products. Both companies will also be audited every other year for the next 20 in order to make sure that they adhere to information security standards.

“I think if the standard consumer, because of this type of activity, looks with somewhat of a cynical eye at such claims that’s good,” James Evans of the University of North Carolina at Chapel Hill told Scientific American. “People have to be able to trust products and claims, and when outlandish claims are exposed, in the long run that’s a good thing.”

Advertisement
ASM
ASM

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo
Advertisement
Horizon Discovery
Horizon Discovery

Popular Now

  1. Antibody Alternatives
    Features Antibody Alternatives

    Nucleic acid aptamers and protein scaffolds could change the way researchers study biological processes and treat disease.

  2. The Mycobiome
    Features The Mycobiome

    The largely overlooked resident fungal community plays a critical role in human health and disease.

  3. Circadian Clock and Aging
    Daily News Circadian Clock and Aging

    Whether a critical circadian clock gene is deleted before or after birth impacts the observed aging-related effects in mice.

  4. Biologist Resigns Amid Sexual Misconduct Probe
Advertisement
Advertisement
Life Technologies